Document
Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017))
Academic Article
Generically Dependent Continuant
Article
RDF description of Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66] (Annals of Oncology (2022) 33(57-66) (S0923753421044963), (10.1016/j.annonc.2021.09.017)) - http://irises.unipv.it/resource/item/497112
Information Content Entity